Shanghai, China

Dasheng Liu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:

goldMedal2 out of 832,843 
Other
 patents

Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Dasheng Liu in Optical Observation Equipment

Introduction

Dasheng Liu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of optical observation equipment, particularly in the identification of malignant tumors. With a total of 2 patents, Liu's work showcases his dedication to advancing medical technology.

Latest Patents

Liu's latest patents include innovative optical observation equipment designed for identifying the forming process of malignant tumors. This equipment features a receiving space and a transparent front end, incorporating a light-guide fiber, a laser emitter, a focusing device, a white light emitter, an image sensor, a high gain amplifier, and an encoding and emitting device. The laser emitter operates at a wavelength of 340 nm±20 nm and an energy of 0.3 to 0.5 mj/min in a pulsing mode. The system alternates between the laser and white light emitters to enhance image acquisition, allowing for precise identification of tumor formation.

Career Highlights

Throughout his career, Liu has focused on developing advanced optical technologies that improve diagnostic capabilities in medical settings. His inventions have the potential to significantly impact the early detection and treatment of malignant tumors, thereby enhancing patient outcomes.

Collaborations

Liu has collaborated with notable colleagues such as Kun Zeng and Guozheng Yan, contributing to a dynamic research environment that fosters innovation and development in medical technology.

Conclusion

Dasheng Liu's contributions to optical observation equipment exemplify the intersection of technology and healthcare. His innovative patents reflect a commitment to improving diagnostic methods for malignant tumors, ultimately benefiting the medical community and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…